Research / UI / Fundamental state Inspectable configuration
State dimensions Filing 0001511737-23-000012 General Corporate
Debt relative to revenue 70th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
181.58% · OPTIONAL · VALID
Capex intensity 60th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.97% · OPTIONAL · VALID
Operating cash generation 0th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-8.03% · OPTIONAL · VALID
Revenue growth 50th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
14.37% · CORE · VALID
Inventory pressure 100th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
130.50% · OPTIONAL · VALID
Gross margin 20th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
40.03% · CORE · VALID
Operating margin 25th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
29.41% · CORE · VALID
R&D intensity 45th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
6.84% · OPTIONAL · VALID
SBC intensity 50th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.22% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 60 states Self-history eligible
Sep 30, 2021 9/9 normalized Level 3 Dec 31, 2021 9/9 normalized Level 3 Mar 31, 2022 9/9 normalized Level 3 Jun 30, 2022 9/9 normalized Level 3 Sep 30, 2022 9/9 normalized Level 3 Dec 31, 2022 9/9 normalized Level 3 Mar 31, 2023 9/9 normalized Level 3 Jun 30, 2023 9/9 normalized Level 3 Sep 30, 2023 9/9 normalized Level 3 Dec 31, 2023 9/9 normalized Level 3 Mar 31, 2024 9/9 normalized Level 3 Jun 30, 2024 9/9 normalized Level 3 Sep 30, 2024 9/9 normalized Level 3 Dec 31, 2024 9/9 normalized Level 3 Mar 31, 2025 9/9 normalized Level 3 Jun 30, 2025 9/9 normalized Level 3 Sep 30, 2025 9/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 159.11%
Current 181.58%
Delta 22.47% Capex Intensity Decreased
Previous 1.74%
Current 0.97%
Delta -0.77% Cash Generation Decreased
Previous 8.43%
Current -8.03%
Delta -16.46% Growth Increased
Previous 8.54%
Current 14.37%
Delta 5.83% Inventory Pressure Increased
Previous 71.21%
Current 130.50%
Delta 59.30% Margin Increased
Previous 34.41%
Current 40.03%
Delta 5.62% Profitability Increased
Previous 24.50%
Current 29.41%
Delta 4.91% R And D Intensity Increased
Previous 6.56%
Current 6.84%
Delta 0.28% Sbc Intensity Increased
Previous 0.21%
Current 0.22%
Delta 0.01% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.